Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array

Tuberculosis

Volumn 97, Issue , 2016, Pages 108-117

  Chen, Tao ^a   Li, Zhenyan ^j   Yu, Li ^k   Li, Haicheng ^a   Lin, Jinfei ^a   Guo, Huixin ^a   Wang, Wei ^c   Chen, Liang ^a   Zhang, Xianen ^b   Wang, Yunxia ^d   Chen, Yuhui ^a   Liao, Qinghua ^b   Tan, Yaoju ^e   Shu, Yang ^a   Huang, Wenyan ^d   Cai, Changhui ^f   Zhou, Zhongjing ^g   Yu, Meiling ^g   Li, Guozhou ⁱ   Zhou, Lin ^a   Zhong, Qiu ^a   Bi, Lijun ^b   Zhao, Meigui ^d   Guo, Lina ^h   Zhou, Jie ^c   more..

^a Research Center for Diabetes Care of Guangdong Province   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c Foshan Fourth People's Hospital   (China)

^d Baoan Chronic Diseases Prevent and Cure Hospital   (China)

^e GUANGZHOU CHEST HOSPITAL   (China)

^f Plastic Surgery Laser Center The Second People's Hospital of Zhongshan City   (China)

^g Chinese Medicine Hospital of Huangpu District   (China)

^h GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

ⁱ Prevention and Treatment for Chronic Disease of Dongguan   (China)

^j JINAN UNIVERSITY   (China)

^k SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

more..

Author keywords

I 309; IFN IL 4; IL 2 TNF ; IL 8; MIG; Tuberculosis

Indexed keywords

COLONY STIMULATING FACTOR 1; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN; EOTAXIN 2; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 11; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; PROTEIN I 309; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; TH1 TH2 BALANCE; UPREGULATION; ADOLESCENT; AGED; CHINA; CLINICAL TRIAL; DRUG EFFECT; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; TIME FACTOR; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; BIOMARKERS; CHINA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PROTEIN ARRAY ANALYSIS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 84958729475     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.12.007     Document Type: Article

References (44)

1. A. Zumla, M. Raviglione, R. Hafner, and C. Fordham von Reyn Tuberculosis N Engl J Med 368 8 2013 745 755
2. P. Glaziou, D. Falzon, K. Floyd, and M. Raviglione Global epidemiology of tuberculosis preface Semin Respir Crit Care Med 34 1 2013 3 16
3. E. Vynnycky, and P.E. Fine Lifetime risks, incubation period, and serial interval of tuberculosis Am J Epidemiol 152 3 2000 247 263
4. S. Burl, U.J. Adetifa, M. Cox, E. Touray, H. Whittle, H. McShane, S.L. Rowland-Jones, and K.L. Flanagan The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life PLoS One 5 8 2010 e12287
5. R. Turner, C. Tweed, and G. Bothamley No proof that BCG protects against infection with Mycobacterium tuberculosis BMJ 349 2014 g5436
6. C. Herzmann, G. Sotgiu, T. Schaberg, M. Ernst, S. Stenger, and C. Lange Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults Eur Respir J 44 4 2014 1087 1090
7. K. Kruczak, M. Duplaga, M. Sanak, A. Cmiel, L. Mastalerz, K. Sladek, and E. Nizankowska-Mogilnicka Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland Scand J Infect Dis 46 9 2014 649 655
8. G.J. Kost, K.N. Hale, T.K. Brock, R.F. Louie, N.L. Gentile, T.K. Kitano, and N.K. Tran Point-of-care testing for disasters: needs assessment, strategic planning, and future design Clin Lab Med 29 3 2009 583 605
9. E. Torrado, and A.M. Cooper Cytokines in the balance of protection and pathology during mycobacterial infections Adv Exp Med Biol 783 2013 121 140
10. C.L. Chung, C.H. Chen, J.R. Sheu, Y.C. Chen, and S.C. Chang Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates Chest 128 2 2005 690 697
11. G. Sharma, R.K. Dutta, M.A. Khan, M. Ishaq, K. Sharma, H. Malhotra, and S. Majumdar IL-27 inhibits IFN-gamma induced autophagy by concomitant induction of JAK/PI3 K/Akt/mTOR cascade and up-regulation of Mcl-1 in Mycobacterium tuberculosis H37Rv infected macrophages Int J Biochem Cell Biol 55 2014 335 347
12. I. Latorre, J. Díaz, I. Mialdea, M. Serra-Vidal, N. Altet, C. Prat, N. Díez, A. Escribano, I. Casas, C. Rodrigo, V. Ausina, M. Ruhwald, and J. Domínguez IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children J Infect 69 6 2014 590 599
13. I. Sauzullo, C.M. Mastroianni, F. Mengoni, A. Ermocida, C. Mascia, A. Salotti, M. Falciano, and V. Vullo Long-term IFN-gamma and IL-2 response for detection of latent tuberculosis infection in healthcare workers with discordant immunologic results J Immunol Methods 414 2014 51 57
14. M. Frahm, N.D. Goswami, K. Owzar, E. Hecker, A. Mosher, E. Cadogan, P. Nahid, G. Ferrari, and J.E. Stout Discriminating between latent and active tuberculosis with multiple biomarker responses Tuberculosis (Edinb) 91 3 2011 250 256
15. D. Anbarasu, C.P. Raja, and A. Raja Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings Cytokine 61 3 2013 747 754
16. M. Armand, V. Chhor, A.d. Lauzanne, V.G. Khourouj, B. Pédron, M. Jeljeli, P. Gressens, A. Faye, and G. Sterkers Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study J Infect 68 1 2014 62 70
17. E. Borgstrom, P. Andersen, F. Atterfelt, I. Julander, G. Källenius, M. Maeurer, I. Rosenkrands, M. Widfeldt, J. Bruchfeld, and H. Gaines Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker PLoS One 7 11 2012 e43438
18. Y.Y. Chen, J.R. Chang, W.F. Huang, S.C. Hsu, S.C. Kuo, J.R. Sun, and H.Y. Dou The pattern of cytokine production in vitro induced by ancient and modern Beijing Mycobacterium tuberculosis strains PLoS One 9 4 2014 e94296
19. P.N. Essone, N.N. Chegou, A.G. Loxton, K. Stanley, M. Kriel, G. Spuy, K.L. Franken, T.H. Ottenhoff, and G. Walzl Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease PLoS One 9 7 2014 e102584
20. J.M. Guerra-Laso, S. Raposo-Garcia, S. Garcia-Garcia, C. Diez-Tascon, and O.M. Rivero-Lezcano Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL-26 as a new candidate gene for tuberculosis susceptibility Immunology 144 2 2014 291 301
21. D. Kassa, L. Ran, W. Geberemeskel, M. Tebeje, A. Alemu, A. Selase, B. Tegbaru, K.L.M.C. Franken, A.H. Friggen, K.E. van Meijgaarden, T.H.M. Ottenhoff, D. Wolday, T. Messele, and D. van Baarle Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis Clin Vaccine Immunol 19 12 2012 1907 1915
22. K.L. Kellar, J. Gehrke, S.E. Weis, A. Mahmutovic-Mayhew, B. Davila, M.J. Zajdowicz, R. Scarborough, P.A. LoBue, A.A. Lardizabal, C.L. Daley, R.R. Reves, J. Bernardo, B.H. Campbell, W.C. Whitworth, and G.H. Mazurek Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens PLoS One 6 11 2011 e26545
23. M.K. Murthy, T. Kaliappan, and A. Raja Cytokine and chemokine responses to selected early secreted antigenic target-6 and culture filtrate protein-10 peptides in tuberculosis J Interferon Cytokine Res 31 3 2011 299 307
24. K. Skogstrand, A.H. Thysen, C.S. Jørgensen, E. Michael Rasmussen, Å.B. Andersen, T. Lillebaek, D.M. Hougaard, and G. Houen Antigen-induced cytokine and chemokine release test for tuberculosis infection using adsorption of stimulated whole blood on filter paper and multiplex analysis Scand J Clin Lab Invest 72 3 2012 204 211
25. F. Abebe, T. Mustafa, A.H. Nerland, and G.A. Bjune Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease Clin Exp Immunol 143 1 2006 180 192
26. E. Rovida, M. Baccarini, M. Olivotto, and P.D. Sbarba Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages Oncogene 21 23 2002 3670 3676
27. W.L. Trepicchio, L. Wang, M. Bozza, and A.J. Dorner IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB J Immunol 159 11 1997 5661 5670
28. J.C. Leemans, S. Florquin, M. Heikens, S.T. Pals, R. van der Neut, and T. van der Poll CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis J Clin Invest 111 5 2003 681 689
29. L. Danelishvili, J. McGarvey, Y.j. Li, and L.E. Bermudez Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells Cell Microbiol 5 9 2003 649 660
30. P.T. Mehrotra, D. Wu, J.A. Crim, H.S. Mostowski, and J.P. Siegel Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes J Immunol 151 5 1993 2444 2452
31. J. Prochazkova, K. Pokorna, and V. Holan IL-12 inhibits the TGF-beta-dependent T cell developmental programs and skews the TGF-beta-induced differentiation into a Th1-like direction Immunobiology 217 1 2012 74 82
32. S. Ghislin, D. Obino, S. Middendorp, N. Boggetto, C. Alcaide-Loridan, and F. Deshayes LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro BMC Cancer 12 2012 455
33. E.A. Garcia-Zepeda, M.E. Rothenberg, R.T. Ownbey, J. Celestin, P. Leder, and A.D. Luster Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia Nat Med 2 4 1996 449 456
34. E. Whittaker, A. Gordon, and B. Kampmann Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One 3 12 2008 e3901
35. O. Butera, T. Chiacchio, S. Carrara, R. Casetti, V. Vanini, S. Meraviglia, G. Guggino, F. Dieli, M. Vecchi, F.N. Lauria, A. Marruchella, P. Laurenti, M. Singh, N. Caccamo, E. Girardi, and D. Goletti New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response BMC Infect Dis 9 2009 182
36. K. Shimokata Tuberculous infection and biological response in man Kekkaku 79 9 2004 541 545
37. N.S. Haque, J.T. Fallon, M.B. Taubman, and P.C. Harpel The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium Blood 97 1 2001 39 45
38. Q. Yang, Y. Cai, W. Zhao, F. Wu, M. Zhang, K. Luo, Y. Zhang, H. Liu, B. Zhou, H. Kornfeld, and X. Chen IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after anti-tuberculosis treatment Clin Vaccine Immunol 21 12 2014 1635 1644
39. V. Boggaram, K.R. Gottipati, X. Wang, and B. Samten Early secreted antigenic target of 6 kDa (ESAT-6) protein of Mycobacterium tuberculosis induces interleukin-8 (IL-8) expression in lung epithelial cells via protein kinase signaling and reactive oxygen species J Biol Chem 288 35 2013 25500 25511
40. J.P. Sikora, D. Chlebna-Sokol, and A. Krzyzanska-Oberbek Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants Arch Immunol Ther Exp (Warsz) 49 5 2001 399 404
41. L. Wang, Y. Cai, Q. Cheng, Y. Hu, and H. Xiao [Imbalance of Th1/Th2 cytokines in patients with pulmonary tuberculosis] Zhonghua Jie He He Hu Xi Za Zhi 25 9 2002 535 537
42. C. Infante-Duarte, and T. Kamradt Th1/Th2 balance in infection Springer Semin Immunopathol 21 3 1999 317 338
43. P.A. Bretscher On the mechanism determining the TH1/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases Scand J Immunol 79 6 2014 361 376
44. N. Gourgouillon, A. de Lauzanne, C.H. Cottart, E. Curis, C. Debord, V.G.E. Khourouj, B. Pédron, A. Faye, and G. Sterkers TNF-alpha/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study Pediatr Res 72 4 2012 370 374